Delapril
As of the edition of 20 October 2026, Delapril is a small molecule: marketed, first approved in 2006 (ES); acts on ACE.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2006
- Kind
- Small molecule
- Brand name
- Vivace
- First approved
- 16 February 2006 (ES)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Chiesi España S.A.U.
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| ACE | Angiotensin-converting enzyme | P12821 |